VCs Could Cash in on Angie’s List and 4 Other IPOs this Week (slideshow)

This could be a very big week for IPOs, with nine offerings aiming to raise $1.5 billion. Of that group, five are VC-backed companies seeking to raise more than $590 million: Angie’s List, Bluestem Brands, Clovis Oncology, Intermolecular and InvenSense.

The offerings are expected to price from Wednesday through Friday, according to Gaskins IPO Desktop.

One venture firm stands to cash in on two of this week’s proposed IPOs: Battery Ventures. If the offerings from Angie’s List and Bluestem Brands are successful, Battery’s combined holdings for the two companies would be worth more than $230 million.

If Angie’s List prices at the top of its range, Battery could make $5.2 million through the sale of part of its stake, and Battery’s remaining shares could be valued at about $117 million.

If Bluestem goes at the top of its range, Battery’s shares would be worth more than $116 million.

The following slideshow breaks down the details of each proposed IPO and the holdings of each company’s venture backers.

(Photo by Ene/Shutterstock)

[slideshow]
[slide title=” Angie’s List”]
Angie’s List
(aka Brownstone Publishing LLC)
Indianapolis, Ind.
http://www.angieslist.com
Description: Provides a website for rating local service providers.
Year founded: 1995
VC to date: $116.6M
Exchange: Nasdaq
Proposed ticker: ANGI
Proposed price: $11-$13
Proposed shares: 8.8M
Underwriters: BofA Merrill Lynch, Allen & Co.
Sources: Thomson Reuters, Renaissance Capital

[slide title=”Bluestem Brands”]
Bluestem Brands, Inc.
Saint Cloud, Minn.
www.bluestembrands.com
Description: Provides private-label and brand-name merchandise, including apparel, appliances, electronics, and kitchen wares, through its catalog and website.
Year founded: 2002
VC to date: $90.93M
Exchange: Nasdaq
Proposed ticker: BSTM
Proposed price: $14-$16
Proposed shares: 10M
Underwriters: Piper Jaffray, Wells Fargo Securities
Sources: Thomson Reuters, Renaissance Capital

[slide title=”Clovis Oncology”]

Clovis Oncology, Inc.
Boulder, Colo.
www.clovisoncology.com
Description: Develops anti-cancer agents.
Year founded: 2009
VC to date: $146.3M
Exchange: NYSE
Proposed ticker: CLVS
Proposed price: $13-$15
Proposed shares: 9.3M
Underwriters: J.P. Morgan, Credit Suisse
Sources: Thomson Reuters, Renaissance Capital

[slide title=”Intermolecular”]

Intermolecular, Inc.
San Jose, Calif.
www.intermolecular.com
Description: Develops semiconductor technology solutions for the communications, consumer electronics, medical device, automotive, and entertainment industries.
Year founded: 2004
VC to date: $73.47M
Exchange: NYSE
Proposed ticker: IMI
Proposed price: $12-$14
Proposed shares: 10M
Underwriters: Morgan Stanley, J.P. Morgan
Sources: Thomson Reuters, Renaissance Capital

[slide title=”InvenSense”]

InvenSense, Inc.
Sunnyvale, Calif.
www.invensense.com
Description: Designs and fabricates micro-electro-mechanical systems (MEMS) technologies for use in video game devices, tablets, cameras and other devices.
Year founded: 2003
VC to date: $53M
Exchange: Nasdaq
Proposed ticker: INVN
Proposed price: $7-$9
Proposed shares: 10M
Underwriters: Goldman Sachs & Co., Morgan Stanley
Sources: Thomson Reuters, Renaissance Capital

[/slideshow]